STAAR Surgical Company (STAA) analyst actions
Rating and price-target actions on STAA in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the STAA overview →
8 measured STAA analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc. | Press release | -1.09% | -8.22% | |
| Broadwood Partners Reiterates Opposition to STAAR Surgical’s Sale to Alcon Following Conclusion of Performative Go-Shop Process | Press release | -0.51% | -3.84% | |
| Yunqi Capital Applauds STAAR Surgical’s Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated | Press release | -0.16% | +5.01% | |
| STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card | Press release | +0.26% | -0.34% | |
| Yunqi Capital, One of STAAR Surgical Company’s Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon | Press release | -0.04% | -0.52% | |
| STAAR Surgical Reiterates Compelling, Premium Cash Value Provided by Alcon Merger | Press release | -0.29% | -1.37% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against STAAR Surgical Company (STAA) And Encourages Shareholders to Reach Out | Press release | +0.50% | +3.49% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against STAAR Surgical Company (STAA) And Encourages Stockholders to Reach Out | Press release | +1.06% | -4.24% |
Keep exploring
More STAA: earnings → · SEC filings → · STAA overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Quest Diagnostics Incorporated (DGX) | 524 | +0.03% | 51% |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 524 | -0.32% | 46% |
| Surface Oncology, Inc. (SURF) | 521 | -0.69% | 36% |
| MAZOR ROBOTICS LTD AMERICAN D (MZOR) | 518 | -0.08% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.